The University of Southampton
Medicine

Research project: OPTIMISE - OPtimising Treatment for MIld Systolic hypertension in the Elderly

Currently Active: 
Yes
Project type: 
Grant

This is a Primary Care based, open label, randomised controlled trial with embedded qualitative components and the aims are: To safely reduce the amount of blood pressure medication taken by older people using self-monitoring of blood pressure. To see if reducing the amount of medication taken by older people results in fewer falls or other harmful events and side-effects. To see if reducing the number of blood pressure lowering medications can improve the quality of life of individuals entering older age.

Project Overview

The population is getting older (over 3 million people [5%] in the UK are >80 years) and the number of people living with multiple long-term conditions taking multiple drugs is increasing. High blood pressure is one of the most common conditions in older patients and up to half of this population receive two or more drugs to treat it. However, recent evidence suggests that large reductions in blood pressure, and too many drug prescriptions may be associated with an increase in serious falls and death in the elderly.

This study aims to assess the safety of reducing the number of drugs prescribed to 540 older patients (>80 years) who have controlled systolic blood pressure on treatment. The trial will compare the proportion of patients with safe systolic blood pressure levels (<150mmHg) at follow-up in those randomly allocated to either reduction of blood pressure lowering medication with self-monitoring or usual care (continued treatment). Quality of life will also be assessed both in questionnaires and through patient interviews. These interviews will be used to understand the barriers and facilitators to antihypertensive medication reduction as well as what it is that older people most value in terms of quality and quantity of life. We will use mathematical modelling to predict the long effects of any observed changes in blood pressure and quality of life and understand whether further research is needed, for instance, a larger scale clinical trial.

Overall, it is hoped that this work will establish whether medication reduction in older patients can be achieved safely and enable us to understand how the drivers of quality of life including side effects of treatment (e.g. falls) and medication burden balance any potential risks.

Local Investigators: Dr Mark Lown and Professor Paul Little

Funder: NIHR SPCR FR12

Duration:
3 years, until May 2019

Contact: optimise@soton.ac.uk

Website: https://www.phctrials.ox.ac.uk/studies/optimise

 

Related research groups

Primary Care & Population Sciences Academic Units

Staff

Share this research project Share this on Facebook Share this on Google+ Share this on Twitter Share this on Weibo

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×